Eleven individual hyperimmune rabbit polyclonal anti-fluorescein Fab fragment preparations were resolved into heterogeneous subfractions based on differential dissociation times from a specific adsorbent. Four Fab subfractions (i.e., 0.1-, 1.0-, 10-, and 100-day elutions) that differed in affinity were characterized and classified according to the extent of the bathochromic shift in the absorption properties of antibody-bound fluorescein ligand. Absorption maxima of bound fluorescein were shifted in all cases to two distinct narrow ranges, namely, 505 to 507 nm or 518 to 520 nm relative to 491 nm for free fluorescein. There was no direct correlation between the two spectral shift populations and antibody affinity, fluorescence polarization, fluorescence quenching, or fluorescence lifetimes of bound ligand. Fluorescence emission maxima varied with the bathochromic shift range. Bound fluorescein ligand, with absorption maxima of 505 to 507 nm and 518 to 520 nm showed fluorescence emission maxima of 519 to 520 nm and 535 nm, respectively. The two spectral shift ranges differed by approximately 14 to 15 nm and/or energies of approximately 1.5 kcal mol(-1) relative to each other and to the absorption maximum for free fluorescein. Spectral effects on the antibody-bound ligand were discussed relative to solvent-water studies and the atomic structure of a high-affinity liganded anti-fluorescein active site.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1023/a:1019789118530 | DOI Listing |
Gels
December 2024
The Department of Chemical Engineering and Biotechnology, Ariel University, Ariel 4070000, Israel.
Buccal drug delivery offers a promising alternative for avoiding gastrointestinal degradation and first-pass metabolism. However, enhancing the buccal epithelial barrier's permeability remains challenging. This study explores the effects of ethanolic extracts from (CM), (CMC), and (ORD) on buccal epithelium permeability in vitro using a TR146 cell-based model.
View Article and Find Full Text PDFBiomed Rep
November 2024
Department of Pharmacology, Gifu University, Gifu 501-1194, Japan.
Gallein is a known Gβγ subunit inhibitor, but its function in bone metabolism, especially in osteoblasts, and its molecular mechanism remains to be elucidated. Osteoprotegerin (OPG), which is secreted from osteoblasts, binds to nuclear factor kB receptor activator (RANK) ligand (RANKL) as a decoy receptor, prevents RANKL-RANK binding, and inhibits bone resorption. IL-6 is not only a bone resorption factor but also as a bone metabolism regulator.
View Article and Find Full Text PDFCarbohydr Polym
January 2025
Departamento de Química Física, Universidad del País Vasco-EHU, Facultad de Ciencia y Tecnología, Apartado 644, 48080 Bilbao, Spain. Electronic address:
Antimicrobial Photodynamic Therapy (aPDT) is an emerging strategy against resistant pathogenic bacteria, a serious global health threat. We describe herein the efficient preparation of photosensitized cellulose nanocrystals (CNC) using trialkoxysilane linkers for covalent incorporation of anionic (Rose Bengal: RB) and cationic (Toluidine blue O: TBO) photosensitizers (PSs), along with a N-alkyl-d-gluconamide ligand to specifically target Escherichia coli, as model nanosystems for aPDT. The synthesized nanomaterials exhibited high PS loading, high singlet oxygen quantum yield comparable to the solution, and good stability in aqueous media with minimal PS release under physiological conditions.
View Article and Find Full Text PDFBMC Ophthalmol
November 2024
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmic and Visual Science Key Laboratory, Beijing, China.
Objective: The cross-sectional study was designed to evaluate the association of ocular surface inflammation with systemic conditions in patients with systemic lupus erythematosus (SLE).
Methods: The study enrolled 30 SLE patients and 30 controls. Ocular symptoms were evaluated using the Ocular Surface Disease Index (OSDI) questionnaire.
Adv Healthc Mater
December 2024
iNano Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, 8000, Denmark.
Drug targeting is a methodology that helps to overcome the side effects of therapeutic molecules. However, insufficient targeting specificity and the on-target/off-site delivery leave much room for improvement in the targeting endeavors. One approach to enhance the specificity of drug targeting is to engineer artificial receptors with recognition ligands not observed in nature.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!